Margarita López‐Trascasa

Author

Also Known As

Avner Reshef, Elvira Morteruel, M L Trascasa, M LOPEZ-TRASCASA, M LOPEZTRASCASA, M Lopez Trascasa, M Lopez-Trascasa, M LÓPEZ-TRASCASA, M López Trascasa, M López-Trascasa

216

Publications

Citations

H-Index

130

Concepts

All Affiliations

Hospital Universitario La Paz Centre for Biomedical Network Research on Rare Diseases Centro de Investigaciones Biológicas Margarita Salas Hospital La Paz Institute for Health Research Consejo Superior de Investigaciones Científicas

About

Margarita López‐Trascasa is an author at Hospital Universitario La Paz specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	53	3.5K
2	Health Sciences	8	8	683
3	Allergy	7	7	589
4	Natural Sciences	4	4	377
5	Public Health	2	2	221

Margarita López‐Trascasa

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome Elena Goicoechea de Jorge, Claire L. Harris, Jorge Esparza-Gordillo, Proceedings of the National Academy of Sciences ImmunohematologyGeneticsComplement Factor BImmunologyHemolytic Uremic Syndrome	2006	443
Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic Syndrome David Pérez-Caballero, Carolina González-Rubio, M. Esther Gallardo, The American Journal of Human Genetics Missense MutationsUrologyC-terminal RegionHaplotype DeterminationGenetic Disorder	2001	289
Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 Jorge Esparza-Gordillo, Elena Goicoechea de Jorge, Alfonso Buil, Human Molecular Genetics	2005	280
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation Rubén Martínez-Barricarte, Meike Heurich, Francisco Valdés-Cañedo, Journal of Clinical Investigation Renal PathologyImmunologyRenal InflammationPathologyGlomerulonephritis	2010	220
Structural and Functional Characterization of Factor H Mutations Associated with Atypical Hemolytic Uremic Syndrome Pilar Sánchez‐Corral, David Pérez-Caballero, Olatz Huarte, The American Journal of Human Genetics UrologyGenetic DisorderGeneticsInherited Metabolic DiseaseHematology	2002	216
Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain O. Roche, Alvaro Blanch, Teresa Caballero, Annals of Allergy Asthma & Immunology Patient RegistryCardiovascular DiseaseC1 Inhibitor DeficiencyHereditary AngioedemaPathology	2005	209
Characterization of complement factor H–related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome Cynthia Abarrategui-Garrido, Rubén Martínez-Barricarte, Margarita López‐Trascasa, Blood	2009	198
C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation Agustín Tortajada, Hugo Yébenes, Cynthia Abarrategui-Garrido, Journal of Clinical Investigation Glomerular DiseaseRenal PathologyImmunologyRenal InflammationPathology	2013	193
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis Marten Trendelenburg, Margarita López‐Trascasa, Eliška Potluková, Nephrology Dialysis Transplantation	2006	177
The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models Rebecca E. Saunders, Cynthia Abarrategui-Garrido, Véronique Frémeaux‐Bacchi, Human Mutation	2006	168

Page 1